In these cases, the major issue is to distinguish FNH-like nodules from hepatocellular carcinoma (HCC ... and is usually diagnosed during childhood. [54] Benign biliary hamartomas, such as ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...